Simple risk score model could help with weaning patients from mechanical circulatory support

byShinshu UniversityA study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned o

Updated on: November 06,2024 0

Simple risk score model could help with weaning patients from mechanical circulatory support

byShinshu UniversityA study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned o

Updated on:November 06,2024 0

Certain diets may protect against heart disease with type 1 diabetes

by Lori SolomonCertain dietary patterns may protect against inflammation and heart disease in adults with type 1 diabetes, according to a study presented duringNUTRITION 2024, the annual meeting

Updated on: July 19,2024 0

Certain diets may protect against heart disease with type 1 diabetes

by Lori SolomonCertain dietary patterns may protect against inflammation and heart disease in adults with type 1 diabetes, according to a study presented duringNUTRITION 2024, the annual meeting

Updated on:July 19,2024 0

Early rheumatoid arthritis tied to hypertension

by Lori SolomonPatients with early rheumatoid arthritis (RA) have a high incidence of prevalent and incident hypertension, according to a studypublishedonline in the August issue ofR

Updated on: November 05,2024 0

Early rheumatoid arthritis tied to hypertension

by Lori SolomonPatients with early rheumatoid arthritis (RA) have a high incidence of prevalent and incident hypertension, according to a studypublishedonline in the August issue ofR

Updated on:November 05,2024 0

A new tool to reclassify heart risk and reduce heart attacks

by Tracey Ellis, Baker Heart and Diabetes InstituteCentral Illustration. The Lipidomic-Enhanced Risk Score Improves Intermediate-Risk Reclassification. Credit:Journal of the American College of

Updated on: July 31,2024 0

A new tool to reclassify heart risk and reduce heart attacks

by Tracey Ellis, Baker Heart and Diabetes InstituteCentral Illustration. The Lipidomic-Enhanced Risk Score Improves Intermediate-Risk Reclassification. Credit:Journal of the American College of

Updated on:July 31,2024 0

EMS training on key skills improves heart attack survival

byUTSouthwestern Medical CenterCredit: Unsplash/CC0 Public DomainEmergency medical services (EMS) agencies that adopt four or more critical best practices have higher rates of survival amo

Updated on: August 08,2024 0

EMS training on key skills improves heart attack survival

byUTSouthwestern Medical CenterCredit: Unsplash/CC0 Public DomainEmergency medical services (EMS) agencies that adopt four or more critical best practices have higher rates of survival amo

Updated on:August 08,2024 0

Throat problems could impair autonomic nervous system's ability to regulate blood pressure

Throat problems could impair autonomic nervous system's ability to regulate blood pressurebyUniversity of SouthamptonPatients with throat problems were less able to regulate their blood pres

Updated on: September 23,2024 0

Throat problems could impair autonomic nervous system's ability to regulate blood pressure

Throat problems could impair autonomic nervous system's ability to regulate blood pressurebyUniversity of SouthamptonPatients with throat problems were less able to regulate their blood pres

Updated on:September 23,2024 0

From Dr. Oz to heart valves: A tiny device charted a contentious path through the FDA

by David Hilzenrath, Holly K. Hacker, KFF Health NewsMitraClip. Credit: Wikimedia CommonsHellerhoffCreative Commons Attribution-Share Alike 3.0 Unported license.In 2013, the FDA approved a

Updated on: July 17,2024 0

From Dr. Oz to heart valves: A tiny device charted a contentious path through the FDA

by David Hilzenrath, Holly K. Hacker, KFF Health NewsMitraClip. Credit: Wikimedia CommonsHellerhoffCreative Commons Attribution-Share Alike 3.0 Unported license.In 2013, the FDA approved a

Updated on:July 17,2024 0

Unlocking new regenerative pathways in iPS cell–derived epicardium for cardiac repair

byKyoto UniversityCredit: Kyoto UniversityEfforts to foster both intrinsic and extrinsic regenerative responses in heart failure have once again brought iPS cell technologies to the forefront, t

Updated on: October 12,2024 0

Unlocking new regenerative pathways in iPS cell–derived epicardium for cardiac repair

byKyoto UniversityCredit: Kyoto UniversityEfforts to foster both intrinsic and extrinsic regenerative responses in heart failure have once again brought iPS cell technologies to the forefront, t

Updated on:October 12,2024 0

Study links early TNF inhibitor treatment to higher heart disease risk in ankylosing spondylitis patients, with caveats

by American College of RheumatologyCredit: Jean Liew et al, The Association of Early TNF Inhibitor Use with Incident Cardiovascular Events in Ankylosing Spondylitis [abstract]. Arthritis Rheumato

Updated on: June 15,2024 7

Study links early TNF inhibitor treatment to higher heart disease risk in ankylosing spondylitis patients, with caveats

by American College of RheumatologyCredit: Jean Liew et al, The Association of Early TNF Inhibitor Use with Incident Cardiovascular Events in Ankylosing Spondylitis [abstract]. Arthritis Rheumato

Updated on:June 15,2024 7

Rural-urban disparities persist in cardiovascular mortality

by Lori SolomonBetween 2010 and 2022, cardiovascular mortality increased in rural areas and decreased in urban areas, according to a study scheduled forpresentationat theAmerican Hea

Updated on: November 27,2024 0

Rural-urban disparities persist in cardiovascular mortality

by Lori SolomonBetween 2010 and 2022, cardiovascular mortality increased in rural areas and decreased in urban areas, according to a study scheduled forpresentationat theAmerican Hea

Updated on:November 27,2024 0

Novel oral medication muvalaplin lowers Lp(a) in a small international trial

byAmerican Heart AssociationCredit: Unsplash/CC0 Public DomainA clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a

Updated on: November 29,2024 0

Novel oral medication muvalaplin lowers Lp(a) in a small international trial

byAmerican Heart AssociationCredit: Unsplash/CC0 Public DomainA clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a

Updated on:November 29,2024 0

Study: lncRNA ZNF593-AS inhibits cardiac hypertrophy and myocardial remodeling by upregulating Mfn2 expression

by Higher Education PressCredit: Xiang Nie, Jiahui Fan, Yanwen Wang, Rong Xie, Chen Chen, Huaping Li, Dao Wen WangResearchpresentedinFrontiers of Medicinedelves into the regula

Updated on: September 07,2024 0

Study: lncRNA ZNF593-AS inhibits cardiac hypertrophy and myocardial remodeling by upregulating Mfn2 expression

by Higher Education PressCredit: Xiang Nie, Jiahui Fan, Yanwen Wang, Rong Xie, Chen Chen, Huaping Li, Dao Wen WangResearchpresentedinFrontiers of Medicinedelves into the regula

Updated on:September 07,2024 0